Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 674454
                    [Title] => Lasofoxifene shown to sharply reduce incidence of breast cancer
                    [Summary] => 
The investigational selective estrogen-receptor modulator laso-foxifene is shaping up as a PEARL of a drug for the prevention of breast cancer.
                    [DatePublished] => 2011-04-10 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

REPRODUCTIVE HEALTH ADVISORY COMMITTEE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 674454
                    [Title] => Lasofoxifene shown to sharply reduce incidence of breast cancer
                    [Summary] => 
The investigational selective estrogen-receptor modulator laso-foxifene is shaping up as a PEARL of a drug for the prevention of breast cancer.
                    [DatePublished] => 2011-04-10 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Lasofoxifene shown to sharply reduce incidence of breast cancer

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | April 10, 2011 - 12:00am

The investigational selective estrogen-receptor modulator laso-foxifene is shaping up as a PEARL of a drug for the prevention of breast cancer.

Opinion